サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1577566

組織足場の世界市場

Tissue Scaffolds

出版日
ページ情報
英文 120 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.41円
組織足場の世界市場
出版日: 2024年10月25日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 120 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

組織足場の世界市場は2030年までに50億米ドルに達する見込み

2023年に26億米ドルと推定される組織足場の世界市場は、2023年から2030年にかけてCAGR 10.1％で成長し、2030年には50億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである天然組織足場は、CAGR 10.4%を記録し、分析期間終了時には30億米ドルに達すると予測されています。合成組織足場分野の成長率は、分析期間中CAGR 9.6%と推定されます。

米国市場は6億7,440万米ドルと推定、中国はCAGR 9.1％で成長予測

米国の組織足場市場は、2023年に6億7,440万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2023-2030年のCAGR 9.1%を牽引し、2030年には7億6,400万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ8.9%と8.0%と予測されています。欧州では、ドイツがCAGR 7.9%で成長すると予測されています。

世界の組織足場市場- 主要動向と促進要因のまとめ

組織足場が現代のヘルスケアと再生医療に不可欠になりつつある理由とは？

組織足場は、組織工学と修復において極めて重要な役割を果たすため、現代のヘルスケアと再生医療においてますます不可欠になってきています。これらの生体材料構造は、細胞が増殖するための枠組みを提供し、傷害、病気、老化によって損傷した組織や臓器の再生を可能にします。組織足場は、体内の細胞外マトリックス（ECM）を模倣し、組織形成に不可欠な細胞接着、増殖、分化の自然なプロセスを促進します。慢性疾患や外傷の増加、高齢化により、特に骨、軟骨、皮膚、血管組織修復などの分野で組織足場の需要が高まっています。再生医療分野の進歩に伴い、ドナーの組織や臓器を必要としない組織再生をサポートする組織足場の能力は、研究・臨床の両面でますます重要になってきています。

さらに、組織足場は生体適合性インプラントの開発に不可欠であり、将来の個別化医療に欠かせないものとなっています。再建手術や創傷治癒において、組織足場は新しい組織成長のためのテンプレートとして機能し、合成材料にありがちな拒絶反応や合併症のリスクなしに、損傷した組織の修復を可能にします。また、これらの構造体は、幹細胞や成長因子と組み合わせて、より早い治癒と回復を促進するために使用されています。臓器移植、がん研究、薬物試験、人工臓器の開発など、様々な用途における組織足場の需要の高まりは、将来のヘルスケアにおけるその重要な役割を裏付けています。再生医療と組織工学が進化し続ける中、世界の組織足場市場は大きな成長を遂げようとしています。

技術の進歩はどのように組織足場の未来を形成しているのか？

技術の進歩は組織足場の分野に革命をもたらし、デザイン、機能性、臨床応用を向上させています。この分野で最も革新的な技術革新のひとつが3Dバイオプリンティングで、複雑な形状や個人化された特徴を持つ組織足場を精密に製作することができます。3Dバイオプリンティングにより、研究者はヒトの組織や臓器の構造を模倣した足場を作成することができ、足場設計の前例のない制御が可能になります。この技術は、損傷した組織の形状や機能に適合する患者固有の足場を作成する上で特に有用であり、個別化された組織再生・修復への道を開くものです。さらに、3Dバイオプリンティングは、複数の細胞タイプ、成長因子、生体材料を一つの足場に組み込むことを可能にし、組織再生をサポートする能力をさらに高める。

バイオプリンティングに加えて、生体材料の進歩も組織足場市場に大きな影響を与えています。研究開発は、天然高分子（コラーゲン、ゼラチン、キトサンなど）や合成高分子（ポリ乳酸、ポリグリコール酸など）などの生分解性・生体適合性材料からなる足場を開発しています。これらの材料は、組織再生のための機械的サポートを提供するだけでなく、時間の経過とともに分解されるため、組織が治癒した後の外科的除去の必要性を減らすことができます。薬物、成長因子、シグナル伝達分子を制御された方法で放出するスマート・スキャフォールドも、もう一つの大きな技術革新です。これらの足場は、損傷部位の細胞分化、血管新生、免疫調節を促進することにより組織再生を促進し、治癒プロセスを加速させ、患者の転帰を改善することができます。

さらに、ナノテクノロジーの統合は、組織足場.例えばナノファイバー足場は、より高い表面積と改善された機械的特性を提供し、より良好な細胞接着と増殖を可能にします。また、抗炎症薬や幹細胞などの治療薬を損傷部位に直接送達し、局所的かつ持続的な治療を可能にするナノ粒子担持足場も開発されています。このような技術の進歩が組み合わさることで、組織足場の可能性が広がり、創傷治癒や骨再生から臓器移植やがん治療まで、幅広い医療応用においてより効果的なものとなっています。技術の進歩に伴い、組織足場は再生医療や組織工学の将来において、ますます重要な役割を果たすことになるでしょう。

ヘルスケアニーズと患者嗜好の変化は、組織足場市場をどのように形成していますか？

ヘルスケアのニーズや患者の嗜好の変化は、世界の組織足場市場を大きく形成しています。特に、患者や医療提供者は、より効果的で侵襲性が低く、より早く治癒するソリューションを求めています。市場に影響を与える主要動向の1つは、個別化医療と患者固有の治療に対する需要の高まりです。3Dバイオプリンティングや個別化ヘルスケアの進歩に伴い、個々の患者に合わせた組織足場の作成にますます注目が集まっています。このシフトの背景には、患者固有の解剖学的・生物学的特徴に合わせて設計された個別化足場が、組織再生の成功率を高め、合併症のリスクを低減できるという認識があります。再建外科、整形外科、創傷治癒などの分野では、個別化された組織足場が臨床結果を改善し、患者の満足度を高めるための好ましい選択肢となりつつあります。

組織足場市場を形成するもう一つの重要な要因は、回復時間の短縮を促進する低侵襲治療への嗜好の高まりです。患者が従来の手術に代わる侵襲性の低い治療法を求める中、組織足場は、合成インプラントや体の他の部分からの移植を必要とせず、自然な組織再生を促進することにより、有望な解決策を提供します。これは、高齢者や免疫系が低下している患者など、侵襲的な処置が高いリスクを伴う可能性がある場合に特に重要です。自然治癒を促進し、回復時間を短縮する組織足場の能力は、より迅速で効率的な治療オプションに対する患者の要求に合致しており、臨床および外来の両方でますます人気が高まっています。

持続可能性と生体適合性もまた、患者と医療提供者の双方にとって重要な検討事項となってきています。患者がインプラントや合成材料の長期的な影響に対する認識を深めるにつれ、生分解性で生体適合性の高い組織足場の需要が高まっています。組織が治癒した後、自然に体内に吸収されるこれらの材料は、インプラントを除去するための追加手術の必要性をなくし、患者の不快感や感染症のリスクを軽減します。ヘルスケア・プロバイダーは、組織再生をサポートするだけでなく、合併症や免疫拒絶反応の可能性を最小限に抑える組織足場を選択するようになってきています。このような嗜好の進化が、組織足場の設計と製造における技術革新を促し、幅広い医療用途における組織足場をより魅力的な選択肢にしています。

組織足場の世界市場成長の原動力は？

組織足場の世界市場の成長は、再生医療の進歩、組織工学ソリューションの需要の増加、慢性疾患や傷害の有病率の上昇など、いくつかの重要な要因によって牽引されています。市場成長の主な促進要因の一つは、組織足場が再生医療における重要なコンポーネントとして認知されつつあることです。研究者による組織再生のメカニズムの解明が進むにつれ、組織足場は骨や軟骨の修復から皮膚や血管の再生まで、幅広い用途に使用されるようになっています。組織足場の細胞成長をサポートし、自然治癒プロセスを促進する能力により、特に外傷、慢性疾患、先天性疾患により組織修復を必要とする患者のための再生療法開発において不可欠なツールとなっています。

もう一つの主要な推進力は、心血管疾患、糖尿病、がんなどの慢性疾患の罹患率の上昇に対処するための効果的な解決策に対するニーズが高まっていることです。これらの疾患はしばしば組織の損傷につながるため、損傷した組織を修復したり置き換えたりできる再生治療に対する需要が高まっています。組織足場、特に幹細胞治療との組み合わせは、機能的組織の再生を促進することにより、これらの病態を治療するための有望な解決策を提供します。例えば、循環器疾患では、組織足場はバイオエンジニアリングされた血管や心臓組織の作成に使用され、腫瘍学では、がん手術後の組織再建の可能性が検討されています。組織足場が幅広い医療ニーズに対応できることが、臨床現場での採用拡大に寄与しています。

加えて、高齢化人口の増加が、特に整形外科や再建用途での組織足場の需要を促進しています。世界人口の高齢化に伴い、変形性関節症、骨粗しょう症、骨折などの疾患の発生率が増加しており、骨や軟骨の再生を促進するソリューションの必要性が高まっています。組織足場は、金属インプラントや自家移植のような従来の治療に代わる、より自然で侵襲性の低い組織修復方法を提供します。組織足場の需要は、特に慢性創傷や潰瘍のリスクが高い糖尿病患者の創傷治療への注目の高まりによっても促進されています。組織足場は、皮膚やその他の組織の再生を促進し、感染症のリスクを低減し、治癒の成果を向上させる高度創傷治癒療法に使用されています。

さらに、バイオマテリアルや3Dバイオプリンティングの進歩により、組織足場の用途は拡大し、様々な医療現場においてより身近で効果的なものとなっています。新しい材料や製造技術が開発されるにつれて、足場を使用して再生できる組織や臓器の範囲は拡大し続け、市場にイノベーションの新たな機会を生み出しています。再生医療の普及、医療費の増加、組織損傷に対処するための革新的なソリューションへのニーズの高まりにより、組織足場の世界市場は今後数年で大きく成長する見込みです。

調査対象企業の例（注目の36社）

  • 3D Biotek, LLC
  • Becton, Dickinson and Company
  • BICO Group AB
  • Corning, Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • Molecular Matrix
  • NuVasive, Inc.
  • Pelo Biotech
  • ReproCELL, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP24337

Global Tissue Scaffolds Market to Reach US$5.0 Billion by 2030

The global market for Tissue Scaffolds estimated at US$2.6 Billion in the year 2023, is expected to reach US$5.0 Billion by 2030, growing at a CAGR of 10.1% over the analysis period 2023-2030. Natural Tissue Scaffolds, one of the segments analyzed in the report, is expected to record a 10.4% CAGR and reach US$3.0 Billion by the end of the analysis period. Growth in the Synthetic Tissue Scaffolds segment is estimated at 9.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$674.4 Million While China is Forecast to Grow at 9.1% CAGR

The Tissue Scaffolds market in the U.S. is estimated at US$674.4 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$764.0 Million by the year 2030 trailing a CAGR of 9.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.9% and 8.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.9% CAGR.

Global Tissue Scaffolds Market – Key Trends & Drivers Summarized

Why Are Tissue Scaffolds Becoming Essential in Modern Healthcare and Regenerative Medicine?

Tissue scaffolds are becoming increasingly vital in modern healthcare and regenerative medicine due to their pivotal role in tissue engineering and repair. These biomaterial structures provide a framework for cells to grow, allowing for the regeneration of tissues and organs damaged by injury, disease, or aging. Tissue scaffolds mimic the extracellular matrix (ECM) in the body, facilitating the natural process of cell adhesion, proliferation, and differentiation, which are crucial for tissue formation. The growing prevalence of chronic diseases, trauma cases, and the aging population has significantly heightened the demand for tissue scaffolds, especially in areas like bone, cartilage, skin, and vascular tissue repair. As the field of regenerative medicine advances, the ability of tissue scaffolds to support tissue regeneration without the need for donor tissues or organs is becoming increasingly important in both research and clinical settings.

Moreover, tissue scaffolds are integral in the development of biocompatible implants, making them essential for the future of personalized medicine. In reconstructive surgery and wound healing, tissue scaffolds serve as templates for new tissue growth, enabling the repair of damaged tissues without the risk of rejection or complications typically associated with synthetic materials. These structures are also being used in combination with stem cells and growth factors to promote faster healing and recovery. The growing demand for tissue scaffolds in various applications, including organ transplantation, cancer research, drug testing, and the development of artificial organs, underscores their crucial role in the future of healthcare. As regenerative medicine and tissue engineering continue to evolve, the global tissue scaffolds market is poised for significant growth.

How Are Technological Advancements Shaping the Future of Tissue Scaffolds?

Technological advancements are revolutionizing the field of tissue scaffolds, enhancing their design, functionality, and clinical applications. One of the most transformative innovations in this area is 3D bioprinting, which allows for the precise fabrication of tissue scaffolds with complex geometries and personalized features. 3D bioprinting enables researchers to create scaffolds that mimic the specific structure of human tissues and organs, offering unprecedented control over scaffold design. This technology is particularly valuable in creating patient-specific scaffolds that match the shape and function of damaged tissues, paving the way for personalized tissue regeneration and repair. Additionally, 3D bioprinting allows for the incorporation of multiple cell types, growth factors, and biomaterials into a single scaffold, further enhancing its ability to support tissue regeneration.

In addition to bioprinting, advancements in biomaterials are significantly impacting the tissue scaffolds market. Researchers are developing scaffolds made from biodegradable and biocompatible materials, such as natural polymers (e.g., collagen, gelatin, and chitosan) and synthetic polymers (e.g., polylactic acid and polyglycolic acid). These materials not only provide mechanical support for tissue regeneration but also degrade over time, reducing the need for surgical removal once the tissue has healed. Smart scaffolds that release drugs, growth factors, or signaling molecules in a controlled manner are another major innovation. These scaffolds can enhance tissue regeneration by promoting cell differentiation, angiogenesis, and immune modulation at the site of injury, accelerating the healing process and improving patient outcomes.

Additionally, the integration of nanotechnology is enhancing the properties of tissue scaffolds. Nanofiber scaffolds, for example, offer a higher surface area and improved mechanical properties, allowing for better cell attachment and growth. Nanoparticle-loaded scaffolds are also being developed to deliver therapeutic agents, such as anti-inflammatory drugs or stem cells, directly to the site of injury, providing localized and sustained treatment. The combination of these technological advancements is expanding the possibilities for tissue scaffolds, making them more effective in a wide range of medical applications, from wound healing and bone regeneration to organ transplantation and cancer treatment. As technology continues to advance, tissue scaffolds will play an increasingly critical role in the future of regenerative medicine and tissue engineering.

How Are Changing Healthcare Needs and Patient Preferences Shaping the Tissue Scaffolds Market?

Changing healthcare needs and patient preferences are significantly shaping the global tissue scaffolds market, particularly as patients and healthcare providers seek more effective, less invasive, and faster healing solutions. One of the major trends influencing the market is the growing demand for personalized medicine and patient-specific treatments. With advancements in 3D bioprinting and personalized healthcare, there is an increasing focus on creating tissue scaffolds tailored to individual patients. This shift is driven by the recognition that personalized scaffolds, designed to match the unique anatomical and biological characteristics of a patient, can improve the success rate of tissue regeneration and reduce the risk of complications. In fields such as reconstructive surgery, orthopedics, and wound healing, personalized tissue scaffolds are becoming a preferred option for improving clinical outcomes and enhancing patient satisfaction.

Another key factor shaping the tissue scaffolds market is the increasing preference for minimally invasive treatments that promote faster recovery times. As patients seek less invasive alternatives to traditional surgeries, tissue scaffolds offer a promising solution by facilitating natural tissue regeneration without the need for synthetic implants or grafts from other parts of the body. This is particularly important in cases where invasive procedures may carry higher risks, such as in elderly patients or those with compromised immune systems. The ability of tissue scaffolds to promote natural healing and reduce recovery times aligns with patient demands for quicker and more efficient treatment options, making them increasingly popular in both clinical and outpatient settings.

Sustainability and biocompatibility are also becoming important considerations for both patients and healthcare providers. As patients become more aware of the long-term effects of implants and synthetic materials, the demand for biodegradable and biocompatible tissue scaffolds is rising. These materials, which are naturally absorbed by the body after the tissue has healed, eliminate the need for additional surgeries to remove implants, reducing patient discomfort and the risk of infection. Healthcare providers are increasingly choosing tissue scaffolds that not only support tissue regeneration but also minimize the potential for complications or immune rejection. These evolving preferences are driving innovation in the design and production of tissue scaffolds, making them a more attractive option for a wide range of medical applications.

What Is Driving the Growth of the Global Tissue Scaffolds Market?

The growth in the global tissue scaffolds market is being driven by several key factors, including advancements in regenerative medicine, increasing demand for tissue engineering solutions, and the rising prevalence of chronic diseases and injuries. One of the primary drivers of market growth is the growing recognition of tissue scaffolds as a critical component in regenerative medicine. As researchers make progress in understanding the mechanisms of tissue regeneration, tissue scaffolds are being used in a wide range of applications, from bone and cartilage repair to skin and vascular regeneration. The ability of tissue scaffolds to support cell growth and promote natural healing processes has made them essential tools in the development of regenerative therapies, particularly for patients who require tissue repair due to trauma, chronic diseases, or congenital conditions.

Another major driver is the increasing need for effective solutions to address the rising incidence of chronic diseases, such as cardiovascular disease, diabetes, and cancer. These conditions often lead to tissue damage, creating a growing demand for regenerative treatments that can repair or replace damaged tissues. Tissue scaffolds, particularly in combination with stem cell therapies, offer a promising solution for treating these conditions by promoting the regeneration of functional tissues. For example, in cardiovascular disease, tissue scaffolds are being used to create bioengineered blood vessels and heart tissues, while in oncology, they are being explored for their potential to reconstruct tissues following cancer surgery. The ability of tissue scaffolds to address a wide range of medical needs is contributing to their increasing adoption in clinical practice.

Additionally, the rising aging population is driving the demand for tissue scaffolds, particularly in orthopedic and reconstructive applications. As the global population ages, the incidence of conditions such as osteoarthritis, osteoporosis, and bone fractures is increasing, leading to a greater need for solutions that promote bone and cartilage regeneration. Tissue scaffolds provide a viable alternative to traditional treatments, such as metal implants or autografts, by offering a more natural and less invasive approach to tissue repair. The demand for tissue scaffolds is also being fueled by the increasing focus on wound care, particularly in diabetic patients, who are at higher risk for chronic wounds and ulcers. Tissue scaffolds are being used in advanced wound healing therapies to promote the regeneration of skin and other tissues, reducing the risk of infection and improving healing outcomes.

Furthermore, ongoing advancements in biomaterials and 3D bioprinting are expanding the applications of tissue scaffolds, making them more accessible and effective in a variety of medical settings. As new materials and fabrication techniques are developed, the range of tissues and organs that can be regenerated using scaffolds continues to grow, creating new opportunities for innovation in the market. With the increasing adoption of regenerative medicine, rising healthcare expenditure, and the growing need for innovative solutions to address tissue damage, the global tissue scaffolds market is poised for significant growth in the coming years.

Select Competitors (Total 36 Featured) -

  • 3D Biotek, LLC
  • Becton, Dickinson and Company
  • BICO Group AB
  • Corning, Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • Molecular Matrix
  • NuVasive, Inc.
  • Pelo Biotech
  • ReproCELL, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tissue Scaffolds - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advancements in 3D Bioprinting Strengthen Business Case for Tissue Scaffold Applications
    • Case Overview: Rising Use of Tissue Scaffolds in Organ Regeneration Bodes Well for Market Growth
    • Technological Innovations in Biomaterials Propel Growth in Tissue Scaffolds Market
    • Increasing Adoption of Tissue Scaffolds in Drug Discovery and Development Drives Market Expansion
    • Case Overview: Growth in Stem Cell Research Fuels Demand for Tissue Scaffolds in Medical Applications
    • Case Overview: Use of Tissue Scaffolds in Orthopedic and Musculoskeletal Regeneration Expands Market Opportunities
    • Rising Demand for Scaffold-Based Wound Healing Solutions Strengthens Business Case for Market Growth
    • Focus on Biodegradable Scaffolds Drives Adoption in Surgical and Medical Applications
    • Increasing Use of Tissue Scaffolds in Cardiovascular and Neural Regeneration Expands Market Scope
    • Technological Innovations in Nanofiber Scaffolds Propel Growth in Tissue Engineering
    • Increasing Focus on Reducing Transplantation Challenges Drives Adoption of Tissue Scaffold
    • Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Tissue Scaffolds Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Tissue Scaffolds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Tissue Scaffolds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Tissue Scaffolds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Natural Tissue Scaffolds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Natural Tissue Scaffolds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Natural Tissue Scaffolds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Synthetic Tissue Scaffolds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Synthetic Tissue Scaffolds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Synthetic Tissue Scaffolds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Tissue Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 11: USA Recent Past, Current & Future Analysis for Tissue Scaffolds by Type - Natural Tissue Scaffolds and Synthetic Tissue Scaffolds - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for Tissue Scaffolds by Type - Natural Tissue Scaffolds and Synthetic Tissue Scaffolds Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: USA 16-Year Perspective for Tissue Scaffolds by Type - Percentage Breakdown of Value Sales for Natural Tissue Scaffolds and Synthetic Tissue Scaffolds for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Tissue Scaffolds by Type - Natural Tissue Scaffolds and Synthetic Tissue Scaffolds - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for Tissue Scaffolds by Type - Natural Tissue Scaffolds and Synthetic Tissue Scaffolds Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: Canada 16-Year Perspective for Tissue Scaffolds by Type - Percentage Breakdown of Value Sales for Natural Tissue Scaffolds and Synthetic Tissue Scaffolds for the Years 2014, 2024 & 2030
  • JAPAN
    • Tissue Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 17: Japan Recent Past, Current & Future Analysis for Tissue Scaffolds by Type - Natural Tissue Scaffolds and Synthetic Tissue Scaffolds - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for Tissue Scaffolds by Type - Natural Tissue Scaffolds and Synthetic Tissue Scaffolds Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: Japan 16-Year Perspective for Tissue Scaffolds by Type - Percentage Breakdown of Value Sales for Natural Tissue Scaffolds and Synthetic Tissue Scaffolds for the Years 2014, 2024 & 2030
  • CHINA
    • Tissue Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for Tissue Scaffolds by Type - Natural Tissue Scaffolds and Synthetic Tissue Scaffolds - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: China Historic Review for Tissue Scaffolds by Type - Natural Tissue Scaffolds and Synthetic Tissue Scaffolds Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: China 16-Year Perspective for Tissue Scaffolds by Type - Percentage Breakdown of Value Sales for Natural Tissue Scaffolds and Synthetic Tissue Scaffolds for the Years 2014, 2024 & 2030
  • EUROPE
    • Tissue Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for Tissue Scaffolds by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for Tissue Scaffolds by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Europe 16-Year Perspective for Tissue Scaffolds by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Tissue Scaffolds by Type - Natural Tissue Scaffolds and Synthetic Tissue Scaffolds - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Tissue Scaffolds by Type - Natural Tissue Scaffolds and Synthetic Tissue Scaffolds Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Tissue Scaffolds by Type - Percentage Breakdown of Value Sales for Natural Tissue Scaffolds and Synthetic Tissue Scaffolds for the Years 2014, 2024 & 2030
  • FRANCE
    • Tissue Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 29: France Recent Past, Current & Future Analysis for Tissue Scaffolds by Type - Natural Tissue Scaffolds and Synthetic Tissue Scaffolds - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: France Historic Review for Tissue Scaffolds by Type - Natural Tissue Scaffolds and Synthetic Tissue Scaffolds Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: France 16-Year Perspective for Tissue Scaffolds by Type - Percentage Breakdown of Value Sales for Natural Tissue Scaffolds and Synthetic Tissue Scaffolds for the Years 2014, 2024 & 2030
  • GERMANY
    • Tissue Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 32: Germany Recent Past, Current & Future Analysis for Tissue Scaffolds by Type - Natural Tissue Scaffolds and Synthetic Tissue Scaffolds - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for Tissue Scaffolds by Type - Natural Tissue Scaffolds and Synthetic Tissue Scaffolds Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Germany 16-Year Perspective for Tissue Scaffolds by Type - Percentage Breakdown of Value Sales for Natural Tissue Scaffolds and Synthetic Tissue Scaffolds for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for Tissue Scaffolds by Type - Natural Tissue Scaffolds and Synthetic Tissue Scaffolds - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for Tissue Scaffolds by Type - Natural Tissue Scaffolds and Synthetic Tissue Scaffolds Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Italy 16-Year Perspective for Tissue Scaffolds by Type - Percentage Breakdown of Value Sales for Natural Tissue Scaffolds and Synthetic Tissue Scaffolds for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Tissue Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 38: UK Recent Past, Current & Future Analysis for Tissue Scaffolds by Type - Natural Tissue Scaffolds and Synthetic Tissue Scaffolds - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for Tissue Scaffolds by Type - Natural Tissue Scaffolds and Synthetic Tissue Scaffolds Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: UK 16-Year Perspective for Tissue Scaffolds by Type - Percentage Breakdown of Value Sales for Natural Tissue Scaffolds and Synthetic Tissue Scaffolds for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 41: Rest of Europe Recent Past, Current & Future Analysis for Tissue Scaffolds by Type - Natural Tissue Scaffolds and Synthetic Tissue Scaffolds - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Rest of Europe Historic Review for Tissue Scaffolds by Type - Natural Tissue Scaffolds and Synthetic Tissue Scaffolds Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Rest of Europe 16-Year Perspective for Tissue Scaffolds by Type - Percentage Breakdown of Value Sales for Natural Tissue Scaffolds and Synthetic Tissue Scaffolds for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Tissue Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 44: Asia-Pacific Recent Past, Current & Future Analysis for Tissue Scaffolds by Type - Natural Tissue Scaffolds and Synthetic Tissue Scaffolds - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Asia-Pacific Historic Review for Tissue Scaffolds by Type - Natural Tissue Scaffolds and Synthetic Tissue Scaffolds Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Asia-Pacific 16-Year Perspective for Tissue Scaffolds by Type - Percentage Breakdown of Value Sales for Natural Tissue Scaffolds and Synthetic Tissue Scaffolds for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 47: Rest of World Recent Past, Current & Future Analysis for Tissue Scaffolds by Type - Natural Tissue Scaffolds and Synthetic Tissue Scaffolds - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Rest of World Historic Review for Tissue Scaffolds by Type - Natural Tissue Scaffolds and Synthetic Tissue Scaffolds Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Rest of World 16-Year Perspective for Tissue Scaffolds by Type - Percentage Breakdown of Value Sales for Natural Tissue Scaffolds and Synthetic Tissue Scaffolds for the Years 2014, 2024 & 2030

IV. COMPETITION